112 related articles for article (PubMed ID: 9380298)
1. [Estrogen therapy in women with postmenopausal osteoporosis].
Zarcone R; Carfora E; Sergio F; Bellini P; Longo M; Tartaglia E; Tomasillo G
Minerva Ginecol; 1997; 49(7-8):355-9. PubMed ID: 9380298
[TBL] [Abstract][Full Text] [Related]
2. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
[TBL] [Abstract][Full Text] [Related]
3. Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
Adachi JD
Can Fam Physician; 1998 Feb; 44():327-32. PubMed ID: 9512836
[TBL] [Abstract][Full Text] [Related]
4. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
[TBL] [Abstract][Full Text] [Related]
7. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
[TBL] [Abstract][Full Text] [Related]
8. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
[TBL] [Abstract][Full Text] [Related]
9. Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
Watts NB
J Reprod Med; 2002 Jan; 47(1 Suppl):82-92. PubMed ID: 11829081
[TBL] [Abstract][Full Text] [Related]
10. [The preventive effect of estrogen and vitamin D on postmenopausal bone loss].
Soda M; Mizunuma H; Honjo S; Okano H; Ibuki Y
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Feb; 45(2):106-12. PubMed ID: 8381451
[TBL] [Abstract][Full Text] [Related]
11. Low bone mineral density and fracture burden in postmenopausal women.
Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
[TBL] [Abstract][Full Text] [Related]
12. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of bone mineral density during estrogen replacement therapy.
Thijssen JH; Druckmann R
Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():29-34. PubMed ID: 10862266
[No Abstract] [Full Text] [Related]
14. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
[TBL] [Abstract][Full Text] [Related]
15. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
16. The effect of different doses of calcitonin on bone mineral density and fracture risk in postmenopausal osteoporosis.
Hizmetli S; Elden H; Kaptanoglu E; Nacitarhan V; Kocagil S
Int J Clin Pract; 1998 Oct; 52(7):453-5. PubMed ID: 10622084
[TBL] [Abstract][Full Text] [Related]
17. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
18. [The effect of a one-year alendronate therapy on postmenopausal osteoporosis. (Results in Hungary of an international multicenter clinical study)].
Bettembuk P; Balogh A
Orv Hetil; 1999 Dec; 140(50):2799-803. PubMed ID: 10647267
[TBL] [Abstract][Full Text] [Related]
19. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
[TBL] [Abstract][Full Text] [Related]
20. Estimating the effects of time-varying treatments: incidence of fractures among postmenopausal Japanese women.
Tanaka S; Matsuyama Y; Shiraki M; Ohashi Y
Epidemiology; 2007 Sep; 18(5):529-36. PubMed ID: 17700241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
